MDA-MB-468 Cells
US$ 395,00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Informações gerais
| Descrição | The MDA-MB-468 cell line is a well-established human breast cancer cell line derived from the pleural effusion of an adult patient with metastatic adenocarcinoma. These cells are characterized by their epithelial morphology and are known for their high degree of aneuploidy. MDA-MB-468 cells are estrogen receptor-negative (ER-) and are often used as a model to study triple-negative breast cancer (TNBC), a subtype of breast cancer that lacks estrogen receptor (ER), progesterone receptor (PR), and HER2/neu expression. This makes MDA-MB-468 a critical tool for research into cancers that do not respond to hormonal therapy or HER2-targeted treatments. Genetically, MDA-MB-468 cells exhibit mutations in the TP53 gene, which is a common occurrence in various forms of cancer and plays a significant role in cell cycle regulation and apoptosis. The cell line also shows amplification of the epidermal growth factor receptor (EGFR) gene, contributing to its utility in studying the EGFR signaling pathway and its implications in cancer progression and treatment resistance. Researchers frequently utilize MDA-MB-468 cells to investigate mechanisms of drug resistance, test new therapeutic agents, and explore the molecular biology of aggressive breast cancers. In addition to their genetic and phenotypic characteristics, MDA-MB-468 cells are known for their ability to form xenografts in immunocompromised mice, making them a valuable model for in vivo studies of tumor growth and metastasis. This cell line's responsiveness to various chemotherapeutic agents and targeted therapies is extensively studied to develop effective treatment strategies for TNBC. Overall, the MDA-MB-468 cell line is a crucial resource for advancing breast cancer research, particularly in the context of triple-negative and EGFR-positive malignancies. |
|---|---|
| Organismo | Human |
| Tecido | Breast |
| Doença | Adenocarcinoma |
| Local da metástase | Pleural effusion |
| Sinônimos | MDA-MB 468, MDA-MB468, MDAMB468, MDA-468, MDA468, MB468, MD Anderson-Metastatic Breast-468 |
Características
| Idade | 51 years |
|---|---|
| Gênero | Female |
| Etnia | African |
| Morfologia | Epithelial |
| Propriedades de crescimento | Adherent |
Dados regulatórios
| Referência | MDA-MB-468 (Cytion catalog number 300279) |
|---|---|
| Nível de biossegurança | 1 |
| NCBI_TaxID | 9606 |
| Número de acesso do Cellosaurus | CVCL_0419 |
Dados biomoleculares
Manuseio
| Meio de cultura | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Suplementos | Supplement the medium with 10% FBS |
| Reagente de dissociação | Accutase |
| Subcultura | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Renovação de fluidos | 2 to 3 times per week |
| Meio de congelamento | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelamento e cultura de células |
|
| Atmosfera de incubação | 37°C, 5% CO2, humidified atmosphere. |
| Condições de envio | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condições de armazenamento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Controle de Qualidade e Análise Molecular
| Esterilidade | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de Análise (CoA)
| Número do lote | Tipo de certificado | Data | Número de catálogo |
|---|---|---|---|
| 300279-813 | Certificado de Análise | 23. May. 2025 | 300279 |
| 300279-160525 | Certificado de Análise | 21. Jul. 2025 | 300279 |
-
Related products
Related products
MDA-MB-175-VII CellsOrganismo Human Tecido Metastatic Doença Invasive breast carcinoma of no special type US$ 550,00*